Annual D&A
$6.08M$419.00K-6.45%
Summary
- Current Value
- As of today, BBIO annual D&A is $6.08M, down -6.45% on
- Historical Performance
- BBIO annual D&A is up +3.97% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- BBIO annual D&A is currently -10.28% below its historical high of $6.77M set on
- 3-Year Low Comparison
- BBIO annual D&A is at its 3-year low
- Sector Comparison
- BBIO annual D&A is higher than 65.18% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $6.08M | -6.5% | +4.0% | – | +2236.5% | |
| Quarterly D&A | $1.40M | -9.1% | -15.0% | – | +5276.9% | |
| TTM D&A | $5.37M | -14.7% | -19.1% | – | +10000.0% | |
| Price | $77.25 | +162.3% | +936.9% | +17.9% | – | |
| Annual SG&A | $288.93M | +91.9% | +50.3% | +206.2% | +2072.1% | |
| Annual Total Expenses | $799.27M | +31.3% | +23.7% | +160.5% | +1722.4% | |
| Annual Operating Expenses | $795.39M | +31.2% | +23.7% | +161.4% | +1713.6% | |
| Annual Revenue | $221.90M | +2285.3% | +218.3% | +447.1% | +100.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.77M | N/A | -10.3% |
| 5Y | $6.77M | -10.3% | |
| All | $6.77M | -10.3% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.08M | at low | |
| 5Y | $3.09M | N/A | +96.7% |
| All | $245.00K | +2379.6% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $6.08M | -6.5% | |
| $6.49M | -4.1% | |
| $6.77M | +15.9% | |
| $5.84M | +89.2% |
| Year | Value | Change |
|---|---|---|
| $3.09M | +1,160.4% | |
| $245.00K | -5.8% | |
| $260.00K | - |
FAQ
What is the current annual D&A of BBIO?
As of today, BBIO annual D&A is $6.08M
What is 1-year change in BBIO annual D&A?
BBIO annual D&A is down -6.45% year-over-year
What is 3-year change in BBIO annual D&A?
BBIO annual D&A is up +3.97% over the past 3 years
How far is BBIO annual D&A from its all-time high?
BBIO annual D&A is currently -10.28% below its historical high of $6.77M set on December 31, 2022
How does BBIO annual D&A rank versus sector peers?
BBIO annual D&A is higher than 65.18% of companies in Healthcare sector
When is BBIO next annual earnings release?
The next annual earnings release for BBIO is on
Quarterly D&A
$1.40M$81.00K+6.15%
Summary
- Current Value
- As of today, BBIO quarterly D&A is $1.40M, up +6.15% on
- Historical Performance
- BBIO quarterly D&A is down -9.10% year-over-year, and down -15.02% over the past 3 years
- All-Time High Comparison
- BBIO quarterly D&A is currently -47.97% below its historical high of $2.69M set on
- 3-Year Low Comparison
- BBIO quarterly D&A is +8.88% above its 3-year low of $1.28M reached on
- Sector Comparison
- BBIO quarterly D&A is higher than 62.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.40M | +6.2% | -9.1% | -15.0% | – | |
| Annual D&A | $6.08M | – | -6.5% | +4.0% | – | |
| TTM D&A | $5.37M | -2.5% | -14.7% | -19.1% | – | |
| Price | $77.25 | +41.0% | +162.3% | +936.9% | +17.9% | |
| Quarterly SG&A | $137.62M | +6.6% | +100.0% | +341.3% | +282.1% | |
| Quarterly Total Expenses | $303.44M | +3.8% | +84.2% | +120.4% | +144.7% | |
| Quarterly Operating Expenses | $249.80M | +4.2% | +32.9% | +103.7% | +95.0% | |
| Quarterly Revenue | $120.70M | +9.2% | +4318.0% | +10000.0% | +1385.2% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.40M | at high | |
| 3Y | $1.66M | N/A | -15.8% |
| 5Y | $2.69M | -48.0% | |
| All | $2.69M | -48.0% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.28M | +8.9% | |
| 3Y | $1.28M | +8.9% | |
| 5Y | $265.00K | +427.6% | |
| All | $26.00K | +5276.9% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of BBIO?
As of today, BBIO quarterly D&A is $1.40M
What is BBIO quarterly D&A most recent change?
BBIO quarterly D&A was up +6.15% on September 30, 2025
What is 1-year change in BBIO quarterly D&A?
BBIO quarterly D&A is down -9.10% year-over-year
How far is BBIO quarterly D&A from its all-time high?
BBIO quarterly D&A is currently -47.97% below its historical high of $2.69M set on June 30, 2021
How does BBIO quarterly D&A rank versus sector peers?
BBIO quarterly D&A is higher than 62.67% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
TTM D&A
$5.37M$140.00K-2.54%
Summary
- Current Value
- As of today, BBIO TTM D&A is $5.37M, down -2.54% on
- Historical Performance
- BBIO TTM D&A is down -14.73% year-over-year, and down -19.15% over the past 3 years
- All-Time High Comparison
- BBIO TTM D&A is currently -20.75% below its historical high of $6.77M set on
- 3-Year Low Comparison
- BBIO TTM D&A is at its 3-year low
- Sector Comparison
- BBIO TTM D&A is higher than 62.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $5.37M | -2.5% | -14.7% | -19.1% | – | |
| Annual D&A | $6.08M | – | -6.5% | +4.0% | – | |
| Quarterly D&A | $1.40M | +6.2% | -9.1% | -15.0% | – | |
| Price | $77.25 | +41.0% | +162.3% | +936.9% | +17.9% | |
| TTM SG&A | -$13.43B | -3465.9% | -5657.3% | -8189.0% | -9480.0% | |
| TTM Revenue | $353.78M | +50.0% | +62.5% | +299.0% | +1512.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $6.08M | N/A | -11.7% |
| 3Y | $6.77M | N/A | -20.8% |
| 5Y | $6.77M | -20.8% | |
| All | $6.77M | -20.8% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.37M | at low | |
| 3Y | $5.37M | at low | |
| 5Y | $1.37M | +293.1% | |
| All | $26.00K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of BBIO?
As of today, BBIO TTM D&A is $5.37M
What is BBIO TTM D&A most recent change?
BBIO TTM D&A was down -2.54% on September 30, 2025
What is 1-year change in BBIO TTM D&A?
BBIO TTM D&A is down -14.73% year-over-year
How far is BBIO TTM D&A from its all-time high?
BBIO TTM D&A is currently -20.75% below its historical high of $6.77M set on December 31, 2022
How does BBIO TTM D&A rank versus sector peers?
BBIO TTM D&A is higher than 62.18% of companies in Healthcare sector
When is BBIO next earnings release?
The next earnings release for BBIO is on
Data Sources & References
- BBIO Official Website bridgebio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1743881/000174388125000012/0001743881-25-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1743881/000095017025024119/0000950170-25-024119-index.htm
- BBIO Profile on Yahoo Finance finance.yahoo.com/quote/BBIO
- BBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bbio